Financings in Brief: Anika Research
This article was originally published in The Gray Sheet
Executive Summary
Anika Research: Hyaluronic acid product manufacturer closes a $2.4 mil. private equity financing sale of 120,000 units, each consisting of a share of convertible preferred stock with a 9% annual dividend rate and a warrant to purchase preferred stock. Axiom Venture Partners purchased $2 mil. of the units, as announced previously ("The Gray Sheet" May 8, p. 14). In addition, "certain officers and directors of Anika purchased $400,000 of units," the company says...